Anti-seizure medication Flashcards
What ASM’s promote inhibition?
Topiramate- partial and tonic clonic
Benzodiazepines-
Valproate- partial and generalised (A, MC, TC)
What ASM’s reduce excitation?
Phenytoin- partial and tonic-clonic Carbamazepine- partial and tonic clonic Lamotrigine- partial and generalised Valproate- partial and generalised Topiramate- partial and tonic clonic Levetiracetam- partial, MC and TC- abscence?
Carbamazepine- characteristics
Sodium channel blocker, strong hepatic enzyme inducer (CYP3A4)- h.metabolism
SE: Dose dependent- diplopia, ataxia, sedation and fatigue
Hyponatremia- SIADH (increases ADH release)
Idiosyncratic- BM suppression, hypersensitivity, hepatic derangement, rash
Phenytoin
Sodium channel blocker used in emergency settings (unresponsive SE)
Acute SE: dizziness, ataxia, fatigue, diplopia, nystagmus, rash, sedation
Chronic SE: gum hyperplasia, coarse face, hirsutism (facial hair) osteopenia ( inc vit D metabolism), low folate, peripheral neuropathy
Idiosyncractic- fever, rash, lymphadenopathy- teratogenic
What induces and reduces phenytoin concentration?
Increased: enzyme inhibitors
Decreased: carbamazepine and antacids (other inducers)
90% protein bound- valproate displaces+ inhibits metabolism, increase free phenytoin/ toxicity
Sodium valproate
Sodium/calcium channel blocker, GABA, glutamate receptor actions
Hepatic metabolism
TERATOGENICITY IN YOUNG WOMEN
Sodium valproate- side effects
Generally well tolerated V A- appetite increase, weight gain L-liver failure P-pancreatitis R-reversible hair loss O-oedema A-ataxia T-teratogenicity, tremor, thrombocytopenia E-encephalopathy (confusion as increased ammonia)
Levetiracetam- drug profile
Few side effects but common ones include irritability, anxiety, fatigue, dizziness, behavioural changes, bone marrow and rarely psychosis
Rare hepatic failure
Acts on SV2A ligand (blocks synaptic vescile release)
Rapid and complete absorprtion, renal excretion and not inhibitor/ substrate CYP450 enzymes
CHOICE IN PREGNANCY
Lamotrigine
Sodium channel modulator, safe teratogenicity wise
Typically well tolerated- idiosyncratic rash/ STEVENS JOHNSON SYNDROME (skin failure of mucosal membrane, blistering and bleeding of mouth etc)
Rash- minimised by slow titration, stop if develops
Insomnia, less cognitive effects, mood stabilising effects
CHOICE IN PREGNANCY
Lamotrigine interactions
Combined oral contraceptive pill
Other AED’s- especially valproate
Toparamate
Sodium/calcium channel blocker- GABA/ glutamate
Used in migraine
enzyme inducer and inhibitor, hepatically eliminated
SE- sedation, anorexia, WEIGHT LOSS, psychiatric, word finding difficulties
Rare SE- kidney stones, acute angle closure glaucoma
TERATOGENIC
AEDs and mental health risk
Levetiracetam- SUICIDE RISK
Interaction with antidepressants
Generally ADs ok to use with ASMs- untreated depression?
Bone health
Care with enzyme inducers, e.g carbamazepine
Vitamin D Catabolism
AEDs and weight gain
Valproate (50% in first 1/2 months)- hyperinsulinaemia, insulin resistance, polycystic ovary syndrome- carbamazepine
Gabapentin+ topiramate indicated
AED hypersensitivity syndrome
Rare, potentially fatal conditions within w1-8 of exposure
rash, fever, tender nodes, hepatitis (50% mortality), eosinophilia, pharyngitis, organ failure
Aromatic AED’s phenytoin/carbamazepine show cross reactivity